➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Merck
Harvard Business School
Dow
McKinsey

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for PF-06650833


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug PF-06650833?

PF-06650833 is an investigational drug.

There have been 10 clinical trials for PF-06650833. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2016.

The most common disease conditions in clinical trials are Arthritis, Rheumatoid, Arthritis, and Hidradenitis Suppurativa. The leading clinical trial sponsors are Pfizer, Yale University, and [disabled in preview].

There are five US patents protecting this investigational drug and fifty-two international patents.

Recent Clinical Trials for PF-06650833
TitleSponsorPhase
IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC)PfizerPhase 2
IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC)Yale UniversityPhase 2
TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATEPfizerPhase 2

See all PF-06650833 clinical trials

Clinical Trial Summary for PF-06650833

Top disease conditions for PF-06650833
Top clinical trial sponsors for PF-06650833

See all PF-06650833 clinical trials

US Patents for PF-06650833

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
PF-06650833   Try Before You Buy Bicyclic-fused heteroaryl or aryl compounds Pfizer Inc. (New York, NY)   Try Before You Buy
PF-06650833   Try Before You Buy Bicyclic-fused heteroaryl or aryl compounds Pfizer Inc. (New York, NY)   Try Before You Buy
PF-06650833   Try Before You Buy IRAK degraders and uses thereof KYMERA THERAPEUTICS, INC. (Cambridge, MA)   Try Before You Buy
PF-06650833   Try Before You Buy Bicyclic-fused heteroaryl or aryl compounds Pfizer Inc. (New York, NY)   Try Before You Buy
PF-06650833   Try Before You Buy Bicyclic-fused heteroaryl or aryl compounds Pfizer Inc. (New York, NY)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for PF-06650833

Drugname Country Document Number Estimated Expiration Related US Patent
PF-06650833 Argentina AR099955 2034-04-04   Try Before You Buy
PF-06650833 Australia AU2015242291 2034-04-04   Try Before You Buy
PF-06650833 Canada CA2944475 2034-04-04   Try Before You Buy
PF-06650833 Chile CL2016002524 2034-04-04   Try Before You Buy
PF-06650833 China CN106458912 2034-04-04   Try Before You Buy
PF-06650833 Costa Rica CR20160456 2034-04-04   Try Before You Buy
PF-06650833 Cuba CU20160149 2034-04-04   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
McKinsey
Baxter
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.